Stay updated on Nivolumab & Lenalidomide in Lymphoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab & Lenalidomide in Lymphoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab & Lenalidomide in Lymphoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Difference
    0.4%
    Check dated 2025-05-08T14:02:18.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.7%
    Check dated 2025-05-01T06:28:06.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has been updated to reflect a new version of the clinical trial information, including the addition of new lymphoma types and the revision of the trial version number. Notably, the principal investigator's name and the collaborating organization have been confirmed.
    Difference
    55%
    Check dated 2025-04-16T20:40:49.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has updated its version from v2.14.3 to v2.14.4, and the date has changed from March 25, 2025, to February 24, 2025.
    Difference
    0.6%
    Check dated 2025-04-09T15:58:47.000Z thumbnail image
  6. Check
    37 days ago
    Change Detected
    Summary
    The page has been updated to reflect a change in terminology from 'Lymphosarcoma' to 'Burkitt Lymphoma' and has been revised from version 2.14.2 to 2.14.3.
    Difference
    0.4%
    Check dated 2025-04-02T00:22:00.000Z thumbnail image
  7. Check
    44 days ago
    Change Detected
    Difference
    0.4%
    Check dated 2025-03-25T17:14:54.000Z thumbnail image

Stay in the know with updates to Nivolumab & Lenalidomide in Lymphoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab & Lenalidomide in Lymphoma Clinical Trial page.